Drugs that contain Fenofibrate

1. List of Antara (micronized) drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8026281 LUPIN Treating metabolic syndrome with fenofibrate
Apr, 2025

(1 year, 10 months from now)

US9314447 LUPIN Reduced dose pharmaceutical compositions of fenofibrate
May, 2033

(9 years from now)

Market Authorisation Date: 30 November, 2004

Treatment: Treating severe hypertriglyceridemia; Treating primary hypercholesterolemia and mixed dyslipidemia

Dosage: CAPSULE;ORAL

How can I launch a generic of ANTARA (MICRONIZED) before it's patent expiration?
More Information on Dosage

ANTARA (MICRONIZED) family patents

3

United States

1

India

1

Switzerland

IB

1

IB

2. List of Fenoglide drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8124125 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(1 year, 3 months from now)

US8481078 SALIX Solid dosage form comprising a fibrate
Oct, 2024

(1 year, 3 months from now)

US9173847 SALIX Tablet comprising a fibrate
Oct, 2024

(1 year, 3 months from now)

US7658944 SALIX Solid dosage form comprising a fibrate
Dec, 2024

(1 year, 6 months from now)

Market Authorisation Date: 10 August, 2007

Treatment: For reducing total cholesterol (total-c), ldl-c, apo-lipoprotein b, or total triglycerides, and treating hypertriglyceridemia; Use of fenofibrate for reducing elevated total cholesterol (total-c), ldl...

Dosage: TABLET;ORAL

How can I launch a generic of FENOGLIDE before it's patent expiration?
More Information on Dosage

FENOGLIDE family patents

14

United States

13

Denmark

5

European Union

4

Canada

3

Korea, Republic of

2

Australia

2

China

2

Japan

1

Brazil

1

Hong Kong

1

Russia

1

Mexico

3. List of Tricor drug patents

TRICOR's oppositions filed in EPO
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7320802 ABBVIE Methods of treatment using nanoparticulate fenofibrate compositions
Feb, 2023

(3 months ago)

US7276249 ABBVIE Nanoparticulate fibrate formulations
Feb, 2023

(3 months ago)

Market Authorisation Date: 05 November, 2004

Treatment: Adjunctive therapy to diet in adults to reduce ldl-c, triglycerides and apo b, and increase hdl-c in patients with primary hypercholesterolemia or mixed dyslipidemia (types iia, iib) and to treat hype...

Dosage: TABLET;ORAL

How can I launch a generic of TRICOR before it's patent expiration?
More Information on Dosage

TRICOR family patents

94

United States

24

Japan

17

European Union

14

Canada

14

Australia

9

Austria

8

Germany

6

Spain

4

Korea, Republic of

4

Denmark

4

Argentina

3

Taiwan

3

China

3

Portugal

3

Cyprus

2

Uruguay

2

Mexico

2

New Zealand

EA

2

EA

2

Norway

1

Brazil

1

Morocco

1

Malaysia

1

South Africa

1

Tunisia

1

Singapore

1

Israel

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in